Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Leica Microsystems, CMED Collaborate

Oct 2011
In vitro diagnostic company China Medical Technologies Inc. (CMED) of Beijing and Leica Biosystems, a division of Leica Microsystems based in Wetzlar, Germany, have established a sales, research and development collaboration to develop and market fluorescence in situ hybridization kits for the Leica Bond system, an automated staining platform. The companies will develop automated solutions for tissue sample tests on HER-2, EGFR and TOP2A genes, which play a role in targeted drug therapy for breast, lung and stomach cancer patients. CMED will sell the kits in China, while Leica will have the option to sell them throughout the rest of the world.

Asia-Pacificautomated FISH kitsBiophotonicsbreast cancer drug therapycancer therapy drugsChinaChina Medical Technologies Inc.CMEDcytologyEGFR geneEuro NewsEuropeFISH kitsGermanyHER-2 genehistopathologyimagingin vitro diagnosticsLeica BiosystemsLeica BONDLeica Microsystemslung cancer drug therapymicroscopesNewsprenatal applicationsstaining platformstomach cancer drug therapytissue sample testsTOP2A gene

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to EuroPhotonics magazine - FREE!